These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1569385)

  • 1. ApoC-IIParis2: a premature termination mutation in the signal peptide of apoC-II resulting in the familial chylomicronemia syndrome.
    Parrott CL; Alsayed N; Rebourcet R; Santamarina-Fojo S
    J Lipid Res; 1992 Mar; 33(3):361-7. PubMed ID: 1569385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A deletion mutation in the ApoC-II gene (ApoC-II Nijmegen) of a patient with a deficiency of apolipoprotein C-II.
    Fojo SS; Stalenhoef AF; Marr K; Gregg RE; Ross RS; Brewer HB
    J Biol Chem; 1988 Dec; 263(34):17913-6. PubMed ID: 3192518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An initiation codon mutation in the apoC-II gene (apoC-II Paris) of a patient with a deficiency of apolipoprotein C-II.
    Fojo SS; de Gennes JL; Chapman J; Parrott C; Lohse P; Kwan SS; Truffert J; Brewer HB
    J Biol Chem; 1989 Dec; 264(35):20839-42. PubMed ID: 2592354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes.
    Reina M; Brunzell JD; Deeb SS
    J Lipid Res; 1992 Dec; 33(12):1823-32. PubMed ID: 1479292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of apoC-II and lipoprotein lipase deficiency.
    Fojo SS; de Gennes JL; Beisiegel U; Baggio G; Stalenhoef AF; Brunzell JD; Brewer HB
    Adv Exp Med Biol; 1991; 285():329-33. PubMed ID: 1858563
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of an apoC-II variant (apoC-IIBethesda) in a kindred with apoC-II deficiency and type I hyperlipoproteinemia.
    Sprecher DL; Taam L; Gregg RE; Fojo SS; Wilson DM; Kashyap ML; Brewer HB
    J Lipid Res; 1988 Mar; 29(3):273-8. PubMed ID: 3379339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nonsense mutation in the apolipoprotein C-IIPadova gene in a patient with apolipoprotein C-II deficiency.
    Fojo SS; Lohse P; Parrott C; Baggio G; Gabelli C; Thomas F; Hoffman J; Brewer HB
    J Clin Invest; 1989 Oct; 84(4):1215-9. PubMed ID: 2477392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide.
    Sakurai T; Sakurai A; Vaisman BL; Amar MJ; Liu C; Gordon SM; Drake SK; Pryor M; Sampson ML; Yang L; Freeman LA; Remaley AT
    J Pharmacol Exp Ther; 2016 Feb; 356(2):341-53. PubMed ID: 26574515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Missense mutation Leu72Pro located on the carboxyl terminal amphipathic helix of apolipoprotein C-II causes familial chylomicronemia syndrome.
    Lam CW; Yuen YP; Cheng WF; Chan YW; Tong SF
    Clin Chim Acta; 2006 Feb; 364(1-2):256-9. PubMed ID: 16153625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein C-II deficiency: identification of a structural variant ApoC-II Padova.
    Fojo SS; Baggio G; Gabelli C; Higuchi K; Bojanovski M; Gregg RE; Brewer HB
    Biochem Biophys Res Commun; 1988 Jul; 154(1):73-9. PubMed ID: 3395348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The apolipoprotein C-II variant apoC-IILys19-->Thr is not associated with dyslipidemia in an affected kindred.
    Zysow BR; Pullinger CR; Hennessy LK; Farese RV; Ghassemzadeh M; Kane JP
    Clin Genet; 1994 Jun; 45(6):292-7. PubMed ID: 7923858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new case of apo C-II deficiency with a nonsense mutation in the apo C-II gene.
    Zanelli T; Catapano AL; Averna MR; Barbagallo CM; Liotta A; Giardina FC; Notarbartolo A
    Clin Chim Acta; 1994 Jan; 224(2):111-8. PubMed ID: 8004780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein C-II deficiency with no rare variant in the APOC2 gene.
    Takase S; Osuga J; Fujita H; Hara K; Sekiya M; Igarashi M; Takanashi M; Takeuchi Y; Izumida Y; Ohta K; Kumagai M; Nishi M; Kubota M; Masuda Y; Taira Y; Okazaki S; Iizuka Y; Yahagi N; Ohashi K; Yoshida H; Yanai H; Tada N; Gotoda T; Ishibashi S; Kadowaki T; Okazaki H
    J Atheroscler Thromb; 2013; 20(5):481-93. PubMed ID: 23470567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single nucleotide substitution in the promoter region of the apolipoprotein C-II gene identified in individuals with chylomicronemia.
    Streicher R; Geisel J; Weisshaar C; Avci H; Oette K; Müller-Wieland D; Krone W
    J Lipid Res; 1996 Dec; 37(12):2599-607. PubMed ID: 9017511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the apoC-II gene in apoC-II deficient patients.
    Fojo SS; Law SW; Sprecher DL; Gregg RE; Baggio G; Brewer HB
    Biochem Biophys Res Commun; 1984 Oct; 124(1):308-13. PubMed ID: 6093789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A G+1 to C mutation in a donor splice site of intron 2 in the apolipoprotein (apo) C-II gene in a patient with apo C-II deficiency. A possible interaction between apo C-II deficiency and apo E4 in a severely hypertriglyceridemic patient.
    Okubo M; Hasegawa Y; Aoyama Y; Murase T
    Atherosclerosis; 1997 Apr; 130(1-2):153-60. PubMed ID: 9126659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel missense mutation in the C-terminal domain of lipoprotein lipase (Glu410-->Val) leads to enzyme inactivation and familial chylomicronemia.
    Previato L; Guardamagna O; Dugi KA; Ronan R; Talley GD; Santamarina-Fojo S; Brewer HB
    J Lipid Res; 1994 Sep; 35(9):1552-60. PubMed ID: 7806969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning and characteristics of a new apolipoprotein C-II mutant identified in three unrelated individuals with hypercholesterolemia and hypertriglyceridemia.
    Pullinger CR; Zysow BR; Hennessy LK; Frost PH; Malloy MJ; Kane JP
    Hum Mol Genet; 1993 Jan; 2(1):69-74. PubMed ID: 8490626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel APOC2 Missense Mutation Causing Apolipoprotein C-II Deficiency With Severe Triglyceridemia and Pancreatitis.
    Ueda M; Dunbar RL; Wolska A; Sikora TU; Escobar MDR; Seliktar N; deGoma E; DerOhannessian S; Morrell L; McIntyre AD; Burke F; Sviridov D; Amar M; Shamburek RD; Freeman L; Hegele RA; Remaley AT; Rader DJ
    J Clin Endocrinol Metab; 2017 May; 102(5):1454-1457. PubMed ID: 28201738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein CII-Padova (Tyr37-->stop) as a cause of chylomicronaemia in an Italian kindred from Siculiana.
    Tuzgöl S; Bijvoet SM; Bruin T; Kastelein JJ; Hayden MR
    J Med Genet; 1994 Aug; 31(8):622-6. PubMed ID: 7815420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.